Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04633655 · ClinicalTrials.gov registry record
International CIPN Assessment and Validation Study
A clinical trial of Quality of Life and Chemotherapy-induced Peripheral Neuropathy, sponsored by University of Milano Bicocca.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 20
- Study locations
NCT04633655: Recruiting study of Quality of Life and Chemotherapy-induced Peripheral Neuropathy, sponsored by University of Milano Bicocca.
NCT04633655 is a study of Quality of Life and Chemotherapy-induced Peripheral Neuropathy that is actively recruiting participants, run by University of Milano Bicocca. The registered enrollment target is 1,000 participants, above the 443-participant average among 107 other Quality of Life trials with a reported enrollment target (126% higher). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04633655, a study of Quality of Life and Chemotherapy-induced Peripheral Neuropathy, is actively recruiting participants, sponsored by University of Milano Bicocca.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.
Primary Outcome
NCI-CTC v.5 sensory and motor (changes from base line to end treatment of a 0-5 score)
Conditions Studied
Interventions
- OTHER outcome measures for CIPN testing
Study Locations (20)
Other
- Brain and Mind Center - Sydney
- Dept. of Neurology, Medical University of Vienna - Vienna
- International Centre for Diarrhoeal Disease Research - Dhaka
- Clínica AMO - Salvador
- The Ottawa Hospital - Ottawa
- Aarhus University Hospital - Aarhus
- Hôpital Percy - Clamart
- CHU Dupuytren - Limoges
- Center for Molecular Medicine - Cologne
- University of Larissa - Larissa
- "Saint Andrew's" State General Hospital - Pátrai
Alabama
- Birmingham School of Nursing, University of Alabama - Birmingham
Georgia
- Northside Hospital - Atlanta
Maryland
- JHU - Baltimore
Michigan
- University of Michigan School of Nursing - Ann Arbor
New York
- Columbia University Irving Medical Center - New York
Ohio
- Cancer Center/Wexner Medical Center - Ohio State Medical Oncology Division - Columbus
Pennsylvania
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-06-08 |
| Est. Completion | 2025-12-31 |
What NCT04633655 shows while recruiting
NCT04633655 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 443-participant average among 107 other Quality of Life trials with a reported enrollment target (126% higher).
The record links to 2 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which outcome measures for CIPN testing is the first listed.
NCT04633655 names 20 study sites across 10 states, led by Other, Alabama, Georgia.
Frequently Asked Questions
What is clinical trial NCT04633655 about?
NCT04633655 is a clinical study titled "International CIPN Assessment and Validation Study". This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.
What is the current status of trial NCT04633655?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2020-06-08. Estimated completion is 2025-12-31.
What conditions does trial NCT04633655 study?
This clinical trial studies the following conditions: Quality of Life, Chemotherapy-induced Peripheral Neuropathy.
What interventions are being tested in trial NCT04633655?
The interventions under investigation include: outcome measures for CIPN testing (OTHER).
Who is sponsoring clinical trial NCT04633655?
This trial is sponsored by University of Milano Bicocca, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04633655 being conducted?
This trial has 20 study locations across Alabama, Georgia, Maryland, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Quality of Life
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04633655's enrollment target sits among peer trials
1,000 8th of 107 higher than 99 of 107 other Quality of Life trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft
RECRUITING · Phase 4
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
A Cardiac Disease Quality of Life Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI